Navigation Links
Genta Announces Second Quarter 2008 Financial Results and Conference Call
Date:7/31/2008

BERKELEY HEIGHTS, N.J., July 31 /PRNewswire-FirstCall/ -- Genta Incorporated (OTC Bulletin Board: GNTA) announced today that the Company will release its second quarter 2008 financial results on Thursday, August 7, 2008. Genta management will host a conference call and live audio webcast to discuss these financial results and corporate activities at 8:00 am EDT.

Participants can access the live call by dialing (877) 634-8606 (U.S. and Canada) or (706) 679-3140 (International). The access code for the live call is Genta Incorporated. The call will also be webcast live at http://www.genta.com/investorrelation/events.html

For investors unable to participate in the live call, a replay will be available approximately two hours after the completion of the call, and will be archived for 30 days. Access numbers for this replay are: (800) 642-1687 (U.S. and Canada) and (706) 645-9291 (International); conference ID number is 57549066.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. Genta is currently recruiting patients to the AGENDA Trial, a global Phase 3 trial of Genasense in patients with advanced melanoma. The leading drug in Genta's Small Molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer-related hypercalcemia that is resistant to hydration. The Company has developed G4544, an oral formulation of the active ingredient in Ganite, that has recently entered clinical trials as a potential treatment fo
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane
2. Genta Submits NDA Amendment to FDA for Genasense as Treatment of Chronic Lymphocytic Leukemia
3. Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs
4. Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights
5. Genta Announces Transfer of its Common Stock to the OTC Bulletin Board
6. Genta Announces Pending Transfer of its Common Stock to the Over-the-Counter Bulletin Board
7. Dr. Elizabeth Brown Joins Argenta TEC
8. Syngenta To Build Major Global Biotech Research Center in Beijing, China
9. Genta Restructures Operations to Focus on Priority Initiatives
10. Genta Granted Extension to Achieve Compliance with NASDAQ Listing Requirements
11. Auditors for Genta Incorporated Express Going Concern Qualification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 2015 HUYA Bioscience International (HUYA) today announced the ... Society of HTLV-1, held this week at the University ... the Society is to promote research on HTLV-1 and ... technology and research related to these fields to advance ... is proud to support this prestigious conference," said ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... needs and expertly narrows down the product choices to a manageable shortlist of ... down the list to models that fit best with the customer’s industry and ...
(Date:8/26/2015)... ... 2015 , ... MediVet Biologics, a leader in Veterinary Regenerative ... open in Manhattan, Kansas in early October, 2015. The location of the lab ... development through collaboration with researchers from Kansas State University’s College of Veterinary Medicine. ...
(Date:8/26/2015)... Maryland Heights, MO (PRWEB) , ... August 26, ... ... is announcing it is increasing its investment in the development and manufacture of ... increase demand. The company’s scientific team's extensive expertise with protein chemistry has ...
Breaking Biology Technology:HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4METTLER TOLEDO Updates Online Scale Selection Tool 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2
... At the end of December,Trinitas Comprehensive Cancer Center became ... of New Jersey to offer cancer patients treatment using,RapidArc(TM) ... VAR ).,RapidArc is a fast, precise form of treatment ... possible with conventional radiation therapy,technologies. By delivering radiation ...
... Jan. 13 Responding to the increased risk to,patient ... Foundation,has announced that the 2009 NPSF Patient Safety Congress ... educational sessions designed to,provide attendees with the new thinking ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080307/AQF053LOGO ) , ...
... and NEW HOPE, Pa., Jan. 13 ... Delhi, announced today that its,Bangalore-based subsidiary, Jubilant ... partnership with BioLeap, LLC, USA. Under ... leading edge computational fragment,based drug design platform ...
Cached Biology Technology:Trinitas Comprehensive Cancer Center Now Offering Cancer Patients Faster, Ultra-Precise Radiation Using New RapidArc Technology 2Trinitas Comprehensive Cancer Center Now Offering Cancer Patients Faster, Ultra-Precise Radiation Using New RapidArc Technology 3Patient Safety in Challenging Economic Times is Focus of NPSF Annual Congress on May 20-22 2Jubilant and BioLeap Announce New Partnership in Drug Discovery 2Jubilant and BioLeap Announce New Partnership in Drug Discovery 3
(Date:8/12/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is proud to announce that iMedNet ... platform, has led the way to significant and unprecedented ...   Q2 2015 and Q1 2015 were, respectively, the ... sold in the company,s 15 year history.  In addition, ...
(Date:8/12/2015)... , Aug. 12, 2015  New research ... can attack Android phones to steal users, fingerprints. ... increasing availability of fingerprint scanners on mobile devices, ... concern. To secure biometrics on mobile devices, HYPR ... augment these convenient authentication systems with strong cryptographic ...
(Date:8/11/2015)... -- Today, ZUK announced its Android smartphone Z1, featuring ... revenues in 2015 that relate to sales of FPC1155 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... smartphone manufacturer in China and we ... 155 for Z1 , ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
... development and successful lab tests of "killer paper," a ... material that helps preserve foods by fighting the bacteria ... Langmuir , contains a coating of silver nanoparticles, ... and colleagues note that silver already finds wide use ...
... advance toward development of a way to combat the terrible ... inflict billions of dollars of damage to crops each year ... Organic Letters . Teck-Peng Loh and colleagues ... food crops such as potatoes and soybeans as well as ...
... on newborn infants for 40 years is finding a second ... an article in the current edition of Chemical & Engineering ... Celia Henry Arnaud notes that collecting drops of blood from ... dry has been used for decades to screen newborns for ...
Cached Biology News:
... or 384-well PCR plates Dimples on both sides ... plates End tabs on Thermo-Mat™ 384 fit into ... sealing is achieved with either Thermo-Mat™ 96 or 384 ... lid thermal cyclers Fully autoclavable May ...
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (Z71,667-7) ... assistance. ID clarifier: barcoded, bulk ...
Packaging: package with 500 l Patent/trademark/license (electronic): (r) Registered trademark of Molecular Probes...
... easy method for the isolation of ... tissues. Most of the isolated mitochondria ... The kit contains extraction buffers for ... Also included is a storage buffer ...
Biology Products: